posit come crisi better
morn report fiscal result weak due impact
compani expect fiscal even wors revenu contract
perspect though may conserv thing improv sequenti
coupl neg call delay surgic robot
potenti longer expect howev intrigu manag
commentari look implement program beyond normal bundl
etc embolden posit hospit custom believ may benefit
compani significantli interest see program
believ financi strength need implement program pay
sale rep tradit level outbreak anticip compani exit
pandem faster near-term carri momentum forward
cy ep
fiscal result impact covid like much med tech hurt
coronaviru outbreak result total sale report miss
bogey adjust model despit compani issu
updat neg impact covid sever week ago gm
bp target due unfavor product mix lower revenu adjust ep
dollar less origin model
guidanc provid conserv commentari manag
compani provid full year fiscal guidanc manag note
fiscal sale feel full impact covid
outbreak result though may bit conserv said surgeri
start back top-lin improv remaind year
expect fiscal growth stack two year basi mean growth
period around
takeaway call neg side ledger coupl key
product delay specif compani expect fiscal
clearli later summer ada data
devic present ada manag seem hedg
see releas import rest diabet commun
releas anoth pump known interim bluetooth featur
autom insulin deliveri suspect uptak modest initi
provid fruit environ continu success sell control iq
slowdown key market competit pressur regulatori delay
largest medic technolog compani global diversifi product offer
cardiolog surgeri spine neurolog diabet
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
takeaway call cont manag also note surgic robot delay
believ six month behind high prioriti still provid
cover sell place da vinci interim posit side ledger
compani financi wherewith keep pay sale rep healthi level even
product dip due delay elect procedur group motiv
procedur volum improv strong bag current new product
sell point addit compani indic number program
work hospit come crisi go beyond typic bundl profit-shar
model discuss past without give much price anticip
program deliv sustain benefit organ crisi
keen see look like
stock thought strong balanc sheet spate new product modest valuat
multipl along conserv commentari outlook view
well posit come crisi better mani name med tech coupl
new program could strengthen relationship hospit custom
intermedi period organ could prove attract investor well base
combin factor rate share ow roll forward multipl
base ep ep roughli line
larg cap peer price target move
page
page
good gener expens incom net incom tax net incom analysi gross gener segment analysi cardiac rhythm heart structur peripher cardiac vascular gastrointestin minim invas therapi restor therapi diabet medtron plc
million except per share data
good sold
percent sale
good sold
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
